Kovaltry recombinant and Lanreotide
Determining the interaction of Kovaltry recombinant and Lanreotide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Kovaltry (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kovaltry recombinant-Lanreotide Acetate
- Kovaltry recombinant-Lanreotide Subcutaneous
- Kovaltry recombinant-Lansoprazole
- Kovaltry recombinant-Lansoprazole Delayed-Release Capsules
- Kovaltry recombinant-Lansoprazole Orally Disintegrating Tablets
- Kovaltry recombinant-Lansoprazole, Amoxicillin, and Clarithromycin
- Lanreotide-KPN Prenatal
- Lanreotide-Krintafel
- Lanreotide-Kristalose
- Lanreotide-Kruschen Salts
- Lanreotide-Krystexxa
- Lanreotide-Kurvelo